Metal accumulation, growth and nutrition of Vernonia polyanthes exposed to lead nitrate and arbuscular mycorrhizal fungi

The association between plants and arbuscular mycorrhizal fungi (AMF) can be used to bioremediate areas contaminated by metals. The objectives of this work were to evaluate the lead (Pb2+) phytoaccumulation capacity, morpho-physiology and nutrition responses of Vernonia polyanthes exposed to a solution amended with concentrations of lead nitrate and arbuscular mycorrhizal fungi. The treatments consisted of increasing doses of Pb2+ as lead nitrate [Pb(NO3)2], two strains of AMF and an absolute control without lead and AMF. Lead negatively affected some morphophysiological variables, reduced 27.3, 25.63, 30.60, and 56.60% shoot length, root collar diameter, number of leaves and leaf area, respectively, besides reducing decreasing chlorophyll a. Lead accumulated in the shoot and roots, the latter at the highest concentrations. However, the translocation factor was above 1, indicating low efficiency. The bioaccumulation factor referring to the roots were above 1. The fungi colonization rate was low, 3.31% for Gigaspora margarita and 2.33% for Acaulospora morrowiae. However, the absorption of lead increased, reflecting in lower values of chlorophyll a, dry mass of root and diameter. Results indicated that the arboreal species V. polyanthes tolerate high concentrations of lead and can accumulate significant amounts in the roots. AMF increase the accumulation of lead in the shoot and can be used in projects aimed at the phytoextraction of metals.

Sequesterpene Lactones Isolated from a Brazilian Cerrado Plant (Eremanthus spp.) as Anti-Proliferative Compounds, Characterized by Functional and Proteomic Analysis, are Candidates for New Therapeutics in Glioblastoma.

Gliomas are responsible for more than 60% of all primary brain tumors. Glioblastoma multiforme (GBM), a grade IV tumor (WHO), is one of the most frequent and malignant gliomas. Despite two decades of advances in the discovery of new markers for GBM, the chemotherapy of choice falls to temozolomide after surgery and radiotherapy, which are not enough to increase the survival of patients to more than 15 months. It is urgent to discover new anti-glioma compounds. Many compounds derived from natural products have been used in the development of anti-tumor drugs. In this work, we have screened six low molecular weight sesquiterpene lactones, isolated from Eremanthus spp., and studied their function as anti-proliferative agents against GBM strains. We demonstrated that two of them, goyazensolide and lychnofolide, were effective in reducing cell viability, preventing the formation of anchorage-dependent colony and were able to pass through a mimetic blood-brain barrier making them candidates for glioma therapy, being more potent than temozolomide, according to in vitro assays for the cell lines tested. Proteomic analysis revealed a number of altered proteins involved in glycolytic metabolism and cellular catabolism.